NM_000256.3(MYBPC3):c.3191-15G>C AND Cardiomyopathy

Germline classification:: Likely benign (1 submission)
Last evaluated:: Dec 16, 2018
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001179179.2

Allele description [Variation Report for NM_000256.3(MYBPC3):c.3191-15G>C]

NM_000256.3(MYBPC3):c.3191-15G>C

Gene:

MYBPC3:myosin binding protein C3 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

11p11.2

Genomic location:

Preferred name:

NM_000256.3(MYBPC3):c.3191-15G>C

HGVS:

NC_000011.10:g.47333348C>G
NG_007667.1:g.24355G>C
NM_000256.3:c.3191-15G>CMANE SELECT
LRG_386t1:c.3191-15G>C
LRG_386:g.24355G>C
NC_000011.9:g.47354899C>G

Links:

dbSNP: rs1360814250

NCBI 1000 Genomes Browser:

rs1360814250

Molecular consequence:

NM_000256.3:c.3191-15G>C - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:: Cardiomyopathy (CMYO)
Synonyms:: Cardiomyopathies
Identifiers:: MONDO: MONDO:0004994; MedGen: C0878544; Human Phenotype Ontology: HP:0001638

Recent activity

Clear Turn Off Turn On

Mesorhizobium sp. strain RMCC ML3261 nitrogenase reductase component II (nifH) g...
Mesorhizobium sp. strain RMCC ML3261 nitrogenase reductase component II (nifH) gene, partial cds
gi|2572567580|gb|ON016034.1|

Nucleotide
PREDICTED: Drosophila ananassae heterogeneous nuclear ribonucleoprotein K homolo...
PREDICTED: Drosophila ananassae heterogeneous nuclear ribonucleoprotein K homolog (LOC6495039), transcript variant X2, mRNA
gi|2119969536|ref|XM_001959151.4|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001343790	Color Diagnostics, LLC DBA Color Health	criteria provided, single submitter (ACMG Guidelines, 2015)	Likely benign (Dec 16, 2018)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001343790

Color Diagnostics, LLC DBA Color Health

criteria provided, single submitter

(ACMG Guidelines, 2015)

Likely benign
(Dec 16, 2018)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Color Diagnostics, LLC DBA Color Health, SCV001343790.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 5, 2022

ClinVar

Relating variation to medicine